Host age and major histocompatibility genotype influence on Rous sarcoma regression in chickens

Area of Science:

• Immunogenetics
• Virology
• Poultry Science

Background:

• Rous sarcoma virus (RSV) induces tumors in chickens, with host factors influencing disease progression.
• The major histocompatibility complex (MHC) plays a crucial role in immune responses and disease resistance.
• Previous studies suggest age can affect tumor development and regression.

Purpose of the Study:

• To investigate the combined influence of host age and B (MHC) genotype on the outcome of RSV-induced tumors.
• To determine if specific MHC genotypes confer differential resistance or susceptibility to RSV tumor development across various ages.

Main Methods:

• Utilized White Leghorn lines (61 and 151) and their crosses segregating for B genotypes.
• Inoculated chickens with RSV at different ages (4 weeks to 88 weeks).
• Monitored tumor incidence, regression rates, and survival across different age groups and B genotypes.

Main Results:

• Younger chickens (4 weeks) exhibited significantly lower tumor regression rates compared to older chickens (6-14 weeks).
• Older chickens (58-88 weeks) with B2/B2 genotype showed higher tumor regression and survival rates than those inoculated at 6 weeks.
• The B2/B2 genotype demonstrated a higher incidence of tumor regression compared to the B5/B5 genotype, irrespective of age.

Conclusions:

• Both host age and specific B (MHC) genotypes are critical determinants in the fate of RSV-induced tumors.
• Older age and the B2/B2 MHC genotype are associated with improved tumor regression and survival following RSV infection.
• These findings highlight the complex interplay between host genetics and age in viral oncogenesis.